Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report (Q61867831)
Jump to navigation
Jump to search
scientific article published on 28 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report |
scientific article published on 28 October 2012 |
Statements
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report (English)
R E Langley
L C Thompson
S P Stenning
L Stevenson
S Falk
M Seymour
F Coxon
G W Middleton
D Smith
L Evans
S Slater
J Waters
D Ford
M Hall
T J Iveson
R D Petty
C Plummer
W H Allum
J M Blazeby
28 October 2012